Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease

Authors: C García, C Palomo-Garo1, M García-Arencibia, JA Ramos, RG Pertwee, and J Fernández-Ruiz. BACKGROUND AND PURPOSE Previous findings have indicated that a cannabinoid, such as Δ9-THCV, which has antioxidant properties and the ability to activate CB2 receptors but to block CB1, might be a promising therapy Read More …